Dana Farber Cancer Institution — Boston, Massachusetts

Dana Farber Cancer Institution is a clinical research site located in Boston, Massachusetts, United States 02215.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Dana Farber Cancer Institution has participated in 2 clinical trials.

Therapeutic areas: Cholangiocarcinoma, Urothelial Cancer, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors.

Sponsors: Taiho Oncology, Inc., Syndax Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Dana Farber Cancer Institution?

Dana Farber Cancer Institution has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Dana Farber Cancer Institution conducted?

Dana Farber Cancer Institution has 2 clinical trials on record. Their work covers Cholangiocarcinoma, Urothelial Cancer, Advanced and Metastatic Cancer Patients With Tumors Harboring FGF/FGFR Tumors.

Is Dana Farber Cancer Institution accredited by Crixeo Health?

Dana Farber Cancer Institution has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Dana Farber Cancer Institution?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.